Immunotherapy in treatment of leishmaniasis

M Akbari, A Oryan, G Hatam - Immunology Letters, 2021 - Elsevier
Leishmaniasis caused by various species of protozoan transmitted by sand fly vectors
occurs as a spectrum of clinical features including cutaneous, mucocutaneous and visceral …

The novel treatments based on tissue engineering, cell therapy and nanotechnology for cutaneous leishmaniasis

Z Abpeikar, M Safaei, AA Alizadeh, A Goodarzi… - International Journal of …, 2023 - Elsevier
Cutaneous leishmaniasis (CL) is a global public health issue. Conventional treatments have
substantial costs, side effects, and parasite resistance. Due to easy application and …

Mesenchymal stem/stromal cells in organ transplantation

D Deo, M Marchioni, P Rao - Pharmaceutics, 2022 - mdpi.com
Organ transplantation is essential and crucial for saving and enhancing the lives of
individuals suffering from end-stage organ failure. Major challenges in the medical field …

Real‐time impact of COVID‐19 pandemic on cutaneous leishmaniasis case finding and strategic planning, preventive interventions, control and epidemiology in a …

M Shams, A Rashidi, J Mohamadi… - Health science …, 2023 - Wiley Online Library
Abstract Background and Aims Cutaneous leishmaniasis (CL) is a severe parasitic disease
affecting people, mostly in underdeveloped nations. As a zoonotic infection yearly incidence …

[HTML][HTML] Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis

A Lafleur, S Daffis, C Mowbray, B Arana - Vaccines, 2024 - mdpi.com
Cutaneous leishmaniasis (CL), caused by protozoan parasites of the Leishmania genus, is
prevalent in tropical and subtropical regions, with important morbidity, particularly in low-to …

Efficacy of mesenchymal stem cells therapy in parasitic infections: are anti-parasitic drugs combined with MSCs more effective?

M Kian, S Mirzavand, S Sharifzadeh, T Kalantari… - Acta Parasitologica, 2022 - Springer
Abstract Purpose Mesenchymal stem cells (MSCs) are mesodermal-origin postnatal stem
cells that are able to self-renew and differentiate into several cell lineages. MSCs possess …

[HTML][HTML] Adipose-Derived Stem Cells' Secretome Attenuates Lesion Size and Parasite Loading in Leishmaniasis Caused by Leishmania Major in Mice

I Khodkar, J Saki, R Arjmand, G Saki… - Iranian Journal of …, 2024 - ncbi.nlm.nih.gov
Background: Stem cell-derived secretome (SE) released into the extracellular space
contributes to tissue repair. The present study aimed to investigate the impact of isolated …

The molecular and histopathological investigations of TLR2 rs5743708 and TLR4 (rs4986790 and rs4986791) polymorphisms effects on cutaneous leishmaniasis …

MH Feiz-Haddad, MA Moradkhani, F Sefat… - Experimental …, 2024 - Elsevier
Cutaneous leishmaniasis (CL), a zoonotic and neglected disease, is prevalent in numerous
regions, particularly in tropical and sub-tropical countries. In Iran, endemic foci of …

Atividade anti-Leishmania spp in silico e in vitro de oxadiazóis sintéticos

CVG Pinheiro - 2024 - repositorio.ufc.br
Globalmente, há 1 bilhão de pessoas em áreas endêmicas e mais de 12 milhões de
pessoas infectadas com a leishmaniose. Contudo, é uma doença negligenciada, uma vez …

[PDF][PDF] Stem cells therapy approach in treatment and protection against parasitic diseases

A Elsawey, S Etewa, N Aboulfotouh - PUJ, 2022 - academia.edu
Parasitic diseases have significant global economic, environmental, and public health
impacts. In recent years, stem cells therapy has become a very promising and advanced …